tiprankstipranks
Trending News
More News >
Corcept Therapeutics Inc. (CORT)
NASDAQ:CORT
US Market

Corcept Therapeutics (CORT) Income Statement

Compare
1,237 Followers

Corcept Therapeutics Income Statement

Last quarter (Q3 2025), Corcept Therapeutics's total revenue was $207.64M, an increase of 13.75% from the same quarter last year. In Q3, Corcept Therapeutics's net income was $19.36M. See Corcept Therapeutics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
$ 675.04M$ 482.38M$ 401.86M$ 365.98M$ 353.87M
Gross Profit
$ 664.16M$ 475.89M$ 396.47M$ 360.70M$ 348.29M
Operating Expenses
$ 527.21M$ 368.61M$ 283.84M$ 236.22M$ 220.09M
Depreciation and Amortization
$ 1.34M$ 1.04M$ 1.26M$ 3.07M$ 2.24M
EBITDA
$ 138.29M$ 108.32M$ 113.89M$ 127.95M$ 130.44M
Operating Income
$ 136.95M$ 107.28M$ 112.63M$ 124.48M$ 128.20M
Other Income/Expenses
$ 24.54M$ 17.27M$ 3.56M$ 529.00K$ 3.40M
Pretax Income
$ 161.49M$ 124.56M$ 116.19M$ 125.01M$ 131.60M
Net Income
$ 139.73M$ 106.14M$ 101.42M$ 112.51M$ 106.01M
Per Share Metrics
Basic EPS
$ 1.35$ 1.02$ 0.95$ 0.97$ 0.92
Diluted EPS
$ 1.23$ 0.94$ 0.87$ 0.89$ 0.85
Weighted Average Shares Outstanding
103.23M 103.56M 106.79M 115.65M 115.41M
Weighted Average Shares Outstanding (Diluted)
113.48M 111.74M 115.97M 125.96M 124.19M
Currency in USD

Corcept Therapeutics Earnings and Revenue History